EcoDrugPlus

Ensembl ID : ENSGACG00000014811
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSGACG00000011914
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSGACG00000016489
Gene Symbol: RPS8A
1 Cross references
327 Possible Orthologues:

Ensembl ID : ENSGACG00000011913
Gene Symbol: RPS7
1 Cross references
370 Possible Orthologues:

Ensembl ID : ENSGACG00000011900
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSGACG00000016956
Gene Symbol: PRKCI
1 Cross references
270 Possible Orthologues:

Ensembl ID : ENSGACG00000018720
Gene Symbol: RPS4X
1 Cross references
497 Possible Orthologues:

Ensembl ID : ENSGACG00000014564
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSGACG00000000197
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSGACG00000011349
Gene Symbol: SRC
1 Cross references
198 Possible Orthologues:

Ensembl ID : ENSGACG00000011280
Gene Symbol: PARP1
1 Cross references
209 Possible Orthologues:

Ensembl ID : ENSGACG00000010551
Gene Symbol: -
Cross references: -
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).